The company rebounded sequentially in 3Q20 while sharpening its focus on digital surgery as a strategic initiative with the acquisition of Holo Surgical.
Despite gaining market share in Japan, the company's sales dropped by double-digits for the third consecutive quarter due to COVID and price reductions.
The company grew +8.3% in 3Q20 due to its new product cadence, contracting wins in large health systems and geographic expansion of its revenue footprint.